Delivery Order SPE2DB22D2006-SPE2DB25FW3JS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,977.38 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets in quantities of 30, with an ultimate completion date of November 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 300 mg tablets (30-count) valued at $9,889.10, with an ultimate completion date of August 7, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) was executed on August 6, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical inventory supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Lamictal XR 300 mg tablets (30-count units) valued at $15,910.51 under a firm fixed-price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $18,248.73 to supply Lamictal XR 50 mg tablets (30-count) with a firm fixed price structure and an ultimate completion date of March 26, 2025. This competitively awarded, non-set-aside contract was executed on March 25, 2025, with performance directed to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,702.10 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,777.37. This delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is unclassified with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $42,766.34 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,432.53 on July 22, 2025, for Lamictal XR 250 mg tablets (30-count packages). The contract is a firm fixed price delivery order without set-aside designation, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal medical supply...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3JSDelivery Order
The Defense Logistics Agency awarded a $5,154.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Lamictal XR 300 mg, a pharmaceutical product used to treat neurological conditions. This non-set-aside, competitively awarded contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical transaction within AmerisourceBergen's broader federal contract portfolio. This award is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally, enabling the company to fulfill diverse medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/12/25 |